New genetic stimulation treatment could help Parkinson’s patients regain mobility

News

Author: AdminPublished: 28 September 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

Researchers from Imperial College London and Newcastle University have used a specially-designed, harmless virus to treat brain cells affected by Parkinson’s disease.

This new approach is documented in a study published in the journal ‘Molecular Neurodegeneration’, and examines a less invasive, more precise method of stimulating cells (known as cholinergic neurons) involved in the gait problems and postural instability experienced by advanced Parkinson’s disease patients.

The non-invasive treatment was given to rats which were treated to recreate the symptoms of Parkinson’s disease. They were then given a drug designed to activate the ‘switch’ and stimulate the target neurons.

Dr Ilsa Pienaar, a junior research fellow on the project, said: “Parkinson’s disease patients experience a complex set of symptoms and we hope to use the same method to understand how different brains contribute to the disease.

“If we can transfer this technique to people, we can help patients regain mobility.”

Go Back

Share this story

Comments


Related articles


Maria Alice and family lead

sponsored article

Advances

How DBS can help improve Parkinson’s mobility issues

Learn about the ACTIVA™ RC Neurostimulator from Medtronic

READ MORE
Escape room by Parkinson's NSW

Global update

No Escape Room: a Parkinson’s campaign like no other

The escape room simulates common Parkinson’s symptoms

READ MORE
Mike Bell poet lead

Perspectives

Why I promise to make poetry, not Parkinson’s disease, my daily challenge

Parkinson’s poet crafts a piece per day for year-long project

READ MORE